Table 2.
Markers | ||
---|---|---|
Positive | Negative | |
Lymphatic | CD90 1,2, LYVE-1 4, VEGFR-3 (Flt-4) 7, PROX-1 22 | vWF 25, PV-1 (PAL-E, PLVAP, MECA32) 52 |
Liver Sinusoidal | LYVE-1 4,6 | PV-1 (PAL-E, PLVAP, MECA32) 34, PROX1* 16 |
Renal Peritubular Capillary | PV-1 (PAL-E, PLVAP, MECA32) 33 | PDGFR-β 33, FSP-1 33 |
Central Nervous System | CD133 32, Sca-1 32 | PV-1 (PAL-E, PLVAP, MECA32) * 53,54 |
Spleen | LYVE-1 4, PV-1 (PAL-E, PLVAP, MECA32) 52 | |
Pancreatic Islet | CD117 (c-kit) 32 | |
Pulmonary | Sca-1 55 | |
Alveolar Capillary | Sca-1 55 | vWF 26 |
Markers indicated with * are positive following injury. Markers in bold are the most commonly used to discriminate endothelial cells belonging to each listed district. Framed markers are used for both murine and human panels.